Some aggressive cancers may respond to anti-inflammatory drugs

Some cancer patients with aggressive tumors may benefit from a class of anti-inflammatory drugs used to treat rheumatoid arthritis, new research suggests. Studying triple-negative breast cancer, researchers found that some aggressive tumors rely on an antiviral pathway that appears to drive inflammation, widely recognized for roles in cancer, rheumatoid arthritis and other inflammatory diseases.